The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; none of the 20 sources its claims cite is checked for support yet.
Expression and purification of isotopically labeled peptide inhibitors and substrates of cAMP-dependant protein kinase A for NMR analysis
Open accessAbstract
Extensive x-ray crystallographic studies carried out on the catalytic-subunit of protein kinase A (PKAc) enabled the atomic characterization of inhibitor and/or substrate peptide analogs trapped at its active site. Yet, the structural and dynamic transitions of these peptides from the free to the bound state are missing. These conformational transitions are central to understanding molecular recognition and enzymatic cycle. NMR allows one to study these phenomena under functionally relevant conditions. However, the amounts of isotopically labeled peptides required for this technique present prohibitive costs for peptide synthesis. To enable NMR studies, we have optimized both expression and purification of isotopically enriched substrate/inhibitor peptides using a recombinant fusion protein system. Three of these peptides corresponded to the cytoplasmic regions of the wild-type and lethal mutants of the membrane protein phospholamban, while the fourth peptide corresponded to the binding epitope of the heat-stable protein kinase inhibitor (PKI5–24). The target peptides were fused to the maltose binding protein (MBP), which is further purified using a His6 tag approach. This convenient protocol allows for the purification of milligram amounts of peptides necessary for NMR analysis.
Overview
CoChat Summary
TL;DR
The paper presents an optimized recombinant MBP-His6-TEV fusion system for producing isotopically labeled ~20-residue PKAc inhibitor/substrate peptides (PKI5–24, PLN1–20, and PLN mutants R9C/R14del) in *E. coli*. The protocol yields milligram quantities of >95% pure peptides suitable for NMR, as demonstrated by ESI-TOF and 1H/15N HSQC spectra.
Key findings
- MBP-His6-TEV fusion constructs expressed in *E. coli* BL21(DE3) gave typical yields of 80–125 mg/L in LB or 60–90 mg/L in M9 minimal media, with >90% purity by SDS-PAGE.
- Final peptide yields from 1 L of media were 3 mg PKI5–24 (0.5 mg peptide per gram wet cell mass), 2 mg PLN1–20 or R14del-PLN1–20 (0.3 mg/g), and 1 mg R9C-PLN1–20 (0.2 mg/g); purities exceeded 95% by analytical HPLC.
- ESI-TOF confirmed peptide masses: PKI5–24 calculated 2279.4 m/z, found 2278.6 m/z; PLN1–20 calculated 2440.8, found 2440.1; R9C-PLN1–20 calculated 2387.9, found 2387.1; R14del-PLN1–20 calculated 2284.4, found 2283.7.
- 1H/15N HSQC spectra showed PKI5–24 with 18 of 20 expected peaks, PLN1–20 and R9C-PLN1–20 with 17 of 20, and R14del-PLN1–20 with 18 of 19; PLN analogues appeared predominantly random coil, while PKI5–24 was more dispersed and possibly had defined secondary structure.
Methods
- Constructs were cloned into pMal-c2e to encode MBP-His6-TEV-peptide fusions for PLN1–20, R9C-PLN1–20, R14del-PLN1–20, and PKI5–24; expression was in *E. coli* BL21(DE3), first in LB then M9 minimal media, induced with 1 mM IPTG.
- Purification involved guanidine-HCl lysis, Ni2+-NTA batch binding, dialysis/refolding, TEV cleavage (~1 mg TEV per 40 mg fusion at 30 °C for 6 h), a second Ni2+-NTA step to remove MBP/TEV, and reverse-phase C18 HPLC; purity was checked by analytical HPLC and mass by ESI-TOF.
- NMR samples contained 1 mM peptide in 20 mM phosphate buffer (pH 6.5), 150 mM KCl, 1 mM NaN3, 5 mM DTT, and 5% D2O; 1H/15N HSQC spectra were acquired at 300 K on a Varian Inova 600 MHz spectrometer.
Limitations
- Stated: under the dilute cleavage conditions, cleaved peptides could not be visualized on SDS-PAGE gels with Coomassie blue or silver stain; cleaved fusion protein also did not bind completely to Ni2+-NTA resin, so small amounts carried into HPLC purification.
- Stated: initial unfolding with 8 M urea caused a +44 amu carbamylation contaminant, and Triton X-100 during cleavage introduced PEG contamination, requiring the use of guanidine-HCl and omission of Triton X-100.
- Evident from the text: this is a methods/expression paper reporting HSQC fingerprints only; no PKAc-bound structural/dynamic data or functional phosphorylation assays are shown, and the method is demonstrated on four ~20-residue peptides with final yields of 1–3 mg per liter.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 17 Not checked · 32 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Trace amounts of PEG co-eluted with these peptides during HPLC purification and obscured proper identification of the target peptides by mass spectrometry analysis, showing a distinct polymeric pattern separated by 44 amu (data not shown).”
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > RESULTS AND DISCUSSION > Protein purification
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and R14del-PLN1–20 displayed 18 of 19 expected peaks (one peak contained overlapping resonances, Fig. 5D).”
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > RESULTS AND DISCUSSION > NMR Spectroscopy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under the dilute conditions used at this step, the cleaved peptides could not be visualized on SDS-PAGE gels using either Coomassie blue dye or silver stain.”
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > RESULTS AND DISCUSSION > Protein purification
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By using MBP-fusion constructs, we were also able to limit the amount of proteolytic degradation of these peptides in E. coli.”
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > CONCLUSIONS
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This convenient protocol allows for the purification of milligram amounts of peptides necessary for NMR analysis.”
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
25 more claims
Create a free account to see all 49 claims and to verify the 20 references still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outliers from the MBP structure may arise from a small difference in pH (∼7.3 used here, vs. pH of 7.0 used previously) and possibly from the slightly different construct used in this study which has an N-terminal His6 tag and an artifact of a TEV-cleavage site that left four extra residues at the C-terminus.26”
From One-Sample Approach to Determine the Relative Orientations of Proteins in Ternary and Binary Complexes from Residual Dipolar Coupling Measurements (2009) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > RESULTS AND DISCUSSION > NMR Spectroscopy
“On the other hand, the more dispersed 1H/15N HSQC spectrum for PKI5–25 may be indicative that this peptide assumes a more defined secondary structure.”
§ Expression and Purification of Isotopically Labeled Peptide Inhibitors and Substrates of cAMP-Dependant Protein Kinase A for NMR Analysis > RESULTS AND DISCUSSION > NMR Spectroscopy
“From these HSQC spectra, PKI5–24 displayed 18 of 20 expected peaks (two peaks contained overlapping resonances, Fig. 5A)”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban
Schmitt, J. P., Kamisago, M., Asahi, M., Li, G. H., Ahmad, F., Mende, U., Kranias, E. G., MacLennan, D. H., Seidman, J. G., & Seidman, C. E. (2003) · Science · doi:10.1126/science.1081578 · Cited by 619
Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
SIMMERMAN, H. K. B., & JONES, L. R. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.921 · Cited by 574
Protein Phosphorylation and Signal Transduction
Graves, J. D., & Krebs, E. G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00056-4 · Cited by 430
Dynamics of cAMP-Dependent Protein Kinase
Johnson, D. A., Akamine, P., Radzio-Andzelm, E., Madhusudan, & Taylor, S. S. (2001) · Chemical Reviews · doi:10.1021/cr000226k · Cited by 393
Haghighi, K., Kolokathis, F., Gramolini, A. O., Waggoner, J. R., Pater, L., Lynch, R. A., Fan, G.-C., Tsiapras, D., Parekh, R. R., Dorn, G. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510519103 · Cited by 359
Structural Framework for the Protein Kinase Family
Taylor, S. S., Knighton, D. R., Zheng, J., Ten Eyck, L. F., & Sowadski, J. M. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002241 · Cited by 334
Allosteric cooperativity in protein kinase A
Masterson, L. R., Mascioni, A., Traaseth, N. J., Taylor, S. S., & Veglia, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709214104 · Cited by 189
Self-citationZamoon, J., Mascioni, A., Thomas, D. D., & Veglia, G. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74681-5 · Cited by 176
Self-citation
Cited by
Dynamics connect substrate recognition to catalysis in protein kinase A
Masterson, L. R., Cheng, C., Yu, T., Tonelli, M., Kornev, A., Taylor, S. S., & Veglia, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.452 · Cited by 216
Self-citationcAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban
Masterson, L. R., Yu, T., Shi, L., Wang, Y., Gustavsson, M., Mueller, M. M., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.06.041 · Cited by 76
Self-citationStrategies for Optimizing the Production of Proteins and Peptides with Multiple Disulfide Bonds
Ma, Y., Lee, C.-J., & Park, J.-S. (2020) · Antibiotics · doi:10.3390/antibiotics9090541 · Cited by 71
Gustavsson, M., Traaseth, N. J., Karim, C. B., Lockamy, E. L., Thomas, D. D., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.015 · Cited by 63
Self-citationArrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains
Zhan, X., Pérez, A., Gimenez, L. E., Vishnivetskiy, S. A., & Gurevich, V. V. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.001 · Cited by 52
Chu, F. J., Jin, X. B., Xu, Y. Y., Ma, Y., Li, X. B., Lu, X. M., Liu, W. B., & Zhu, J. Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/340267 · Cited by 18
High‐level expression and large‐scale preparation of soluble HBx antigen from Escherichia coli
Liu, D., Zou, L., Li, W., Wang, L., & Wu, Y. (2009) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20090116 · Cited by 15
Tonelli, M., Masterson, L. R., Cornilescu, G., Markley, J. L., & Veglia, G. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904766g · Cited by 10
Self-citationRaran‐Kurussi, S., Sharwanlal, S. B., Balasubramanian, D., & Mote, K. R. (2021) · Protein Expression and Purification · doi:10.1016/j.pep.2021.105991 · Cited by 10
Xiao, S., Zhao, X., Finkielstein, C. V., & Capelluto, D. G. S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2604 · Cited by 4
Patil, S., Saleena, L. M., Kim, Y., Wéber, E., & von Grafenstein, H. (2011) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-011-9251-2 · Cited by 2
Lipid-Mediated Folding/Unfolding of Phospholamban as a Regulatory Mechanism for the Sarcoplasmic
Gustavsson, M., Traaseth, N. J., Karim, C. B., Lockamy, E. L., Thomas, D. D., & Veglia, G. (2011)
Self-citationFosfolambaanin tuottaminen ja puhdistus
Tuomensalo-Porkka, E. (2024) · Theseus (Ammattikorkeakoulujen)
Metadata
- Authors
- Masterson, L. R., Bortone, N., Yu, T., Ha, K. N., Gaffarogullari, E. C., Nguyen, O., & Veglia, G.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Veglia, Gianluigi
- Venue
- Protein Expression and Purification
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 64
- Issue
- 2
- Pages
- 231-236
- ISSN
- 1046-5928 (ISSN-L)
- PMC
- PMC2699774
- OpenAlex
- W2118935037
- Semantic Scholar
- cbd399b4fdad237d468b063d6831ce90ac845651
- Cited by
- 13
- References
- 19
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 1 · 2014: 2 · 2013: 1
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Protein Expression and Purification (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K02HL080081)
- National Institute of General Medical Sciences (R01GM072701, R01GM064742, T32GM008700)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- protein kinase A, protein kinase A catalytic subunit, peptide inhibitors, peptide substrates, phospholamban, maltose-binding protein fusion, recombinant peptide expression, peptide purification, conformational change, NMR spectroscopy
- MeSH terms
- Amino Acid Sequence, Binding Sites, Carrier Proteins, Isotope Labeling, Models, Genetic, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Peptide Fragments, Recombinant Fusion Proteins, Substrate Specificity, Cyclic AMP-Dependent Protein Kinases, Catalytic Domain, Maltose-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.